International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICRTET-4
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 4
July-August 2026
Indexing Partners
Development, Optimization, Characterization and Evaluation of Ibrutinib-Loaded Chitosan-Shelled Nanobubbles for Ultrasound-Responsive Targeted Drug Delivery
| Author(s) | Mr. Ponnaganti Murali, Dr. Rakesh Kumar Meel, Dr. Narendra Kumar Nyola |
|---|---|
| Country | India |
| Abstract | The present study focused on the development of nanosized Ibrutinib-loaded nanobubbles using a chitosan-based shell system. A 3³ Box–Behnken Design (BBD) was employed to investigate the influence of three formulation variables, namely L-α-phosphatidylcholine (A), chitosan concentration (B), and palmitic acid concentration (C), on the particle size and polydispersity index (PDI) of the prepared nanobubbles. A total of 17 experimental runs were generated randomly using Design Expert® software, and the obtained data were evaluated through multiple regression analysis. Numerical optimization was applied to identify the optimum formulation by setting suitable constraints for the response variables. Three optimized formulations (B1–B3) were selected and further characterized. Morphological analysis confirmed the formation of well-defined core–shell nanobubbles with particle sizes ranging between 150 and 200 nm. The optimized nanobubbles demonstrated an encapsulation efficiency of 82.58% and a drug loading capacity of 17% for Ibrutinib. In vitro drug release studies showed that the optimized nanobubble formulation released 93.52% of Ibrutinib within 24 hours, which was considerably higher than the release observed from the conventional Ibrutinib suspension. Cellular uptake studies using HepG2 cells revealed enhanced fluorescence, with a mean fluorescence intensity of 6.12, approximately 1.5-fold greater than that obtained with Ibrutinib-loaded nanobubbles in the absence of ultrasound exposure. Furthermore, in vitro cytotoxicity results indicated that ultrasound-assisted nanobubbles promoted efficient intracellular drug release and improved therapeutic sensitivity. Overall, the findings suggest that chitosan-shelled Ibrutinib nanobubbles represent a promising platform for contrast-enhanced tumor imaging as well as targeted therapeutic drug delivery. |
| Keywords | Ibrutinib, B-cell cancer, chitosan-shelled nanobubbles, perfluoropentane, Box–Behnken Design (BBD) |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 4, July-August 2026 |
| Published On | 2026-08-24 |
| DOI | https://doi.org/10.36948/ijfmr.2026.v08i04.86545 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals